Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 277

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Frequency and clinical correlates of anti–neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy

Nobile‐Orazio, E., Manfredini, E., Carpo, M., Meucci, N., Monaco, S., Ferrari, S., Bonetti, B., Cavaletti, G., Gemignani, F., Durelli, L., Barbieri, S., Allaria, S., Sgarzi, M., Scarlato, G.·1994·Annals of Neurology

Abstract

We studied the frequency and clinical correlates of different IgM specificities in 75 patients with neuropathy associated with IgM monoclonal gammopathy. Patients were tested for IgM reactivity with the myelin‐associated glycoprotein, PO, neurofilaments, and tubulin by immunoblot; with GM1, asialo‐GM1, GM2, GD1a, GD1b, sulfatide, and chondroitin sulfate C by enzyme‐linked immunosorbent assay; and with brain and nerve glycolipids by overlay highperformance thin‐layer chromatography. Forty‐two patients (56%) had high titers of IgM antibodies to MAG; 4 (5%), to sulfatide (1 also to myelin‐associated glycoprotein); 4 (5%), to the 200‐kd neurofilament (2 also to myelin‐associated protein); and 1 each, to GD1b and chondroitin sulfate C. No reactivity was found in 26 patients (35%). More patients with anti–myelin‐associated glycoprotein IgM (62%) than with unknown IgM reactivity (31%) had a predominantly sensory neuropathy (p < 0.025). Nerve conduction findings were consistent with a demyelinating neuropathy in 77% of patients reactive to myelin‐associated glycoprotein and 24% with unknown reactivity (p < 0.0001) and the mean conduction velocity of peroneal nerve was lower in the former group (22.9 m/sec) than in the latter group (39.6 m/sec) (p < 0.000001). Patients with anti–sulfatide IgM had a sensorimotor neuropathy with morphological evidence of demyelination while anti–neurofilament IgM was not associated with homogeneous findings. Patients with anti–GD1b or anti–chondroitin sulfate C IgM had a predominantly motor impairment. The frequent occurrence of anti–neural IgM antibodies in neuropathy associated with IgM gammopathy, and their frequent, though not constant association with similar neuropathy features, support their possible pathogenetic role in the neuropathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.410360313

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 277

Metadata

Authors
Nobile‐Orazio, E., Manfredini, E., Carpo, M., Meucci, N., Monaco, S., Ferrari, S., Bonetti, B., Cavaletti, G., Gemignani, F., Durelli, L., Barbieri, S., Allaria, S., Sgarzi, M., & Scarlato, G.
Venue
Annals of Neurology
Publisher
Wiley
Published
1994-09
Volume
36
Issue
3
Pages
416-424
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2138403718
Cited by
277
References
24
FWCI
5.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Frequency and clinical correlates of anti–neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. https://app.cochat.ai/papers/10.1002/ana.410360313
The paper
Nobile‐Orazio, E., Manfredini, E., Carpo, M., Meucci, N., Monaco, S., Ferrari, S., Bonetti, B., Cavaletti, G., Gemignani, F., Durelli, L., Barbieri, S., Allaria, S., Sgarzi, M., & Scarlato, G. (1994). Frequency and clinical correlates of anti–neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Annals of Neurology. https://doi.org/10.1002/ana.410360313

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.